Who is sponsoring NCT04474665?

NCT04474665 is sponsored by Spine Institute of Louisiana Foundation.

What drugs are being tested in NCT04474665?

Interventions in NCT04474665: Reverse shoulder arthroplasty utilizing Blueprint Software.

What condition does NCT04474665 study?

NCT04474665 studies Reverse Shoulder Replacement.

Is NCT04474665 still recruiting?

NCT04474665 is currently status unknown. Last updated 17 July 2020.

Last reviewed 2020-07-17 · How we verify

NCT04474665

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tornier Blueprint Planning Software in Patients Receiving Reverse Shoulder Arthroplasty

Status unknown NA Last updated 17 July 2020

What this trial tests

NA trial testing Reverse shoulder arthroplasty utilizing Blueprint Software in Reverse Shoulder Replacement in 20 participants. Status unknown.

Timeline

16 March 2020

Primary endpoint
1 June 2021

1 June 2021

Quick facts

Lead sponsor	Spine Institute of Louisiana Foundation
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	16 March 2020
Primary completion	1 June 2021
Estimated completion	1 June 2021
Sites	1 location across United States

Drugs / interventions tested

Reverse shoulder arthroplasty utilizing Blueprint Software

Conditions studied

Reverse Shoulder Replacement — all drugs for Reverse Shoulder Replacement →

Sponsor

Spine Institute of Louisiana Foundation

Who can join

18 and older, any sex, with Reverse Shoulder Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare sizing determined in pre-operative planning of reverse shoulder arthroplasty to operative implant size selected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Reverse Shoulder Replacement

Currently open trials in the same condition.

NCT06869343 — Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture · NA · recruiting
NCT06873022 — EMG Biofeedback and NMES of Deltoid in Patients With rTSA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04474665 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Spine Institute of Louisiana Foundation
Last refreshed: 17 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04474665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing